E-LIB Suche - Ergebnisse für: Xiao, Bo-Ya

1

Irinotecan plus temozolomide in relapsed Ewing sarcoma: an ..:

Wang, Bi-Cheng ; Xiao, Bo-Ya ; Lin, Guo-He
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

2

A Bayesian network meta-analysis of the primary definitive ..:

Zhang, Zhan-Jie ; Shi, Liang-Liang ; Hong, Xiao-Hua...
PLOS ONE. 17 (2022) 3 - p. e0265551 , 2022

Link: https://doi.org/10.1371/..

3

A pooled analysis of adding olanzapine to guideline-recomme..:

Xiao, Bo-Ya ; Su, Tong ; Huang, Yu-Jia...
Supportive Care in Cancer. 30 (2021) 3 - p. 2445-2453 , 2021

Link: https://doi.org/10.1007/..

4

6 versus 12 months of adjuvant trastuzumab in HER2+ early b..:

Wang, Bi-Cheng ; Xiao, Bo-Ya ; Fan, Ji-Quan...
Medicine. 100 (2021) 10 - p. e24995 , 2021

Link: https://doi.org/10.1097/..

5

Corrigendum to "Efficacy and Safety of First-Line Immunothe..:

Wang, Bi-Cheng ; Xiao, Bo-Ya ; Li, Peng-Cheng...
Journal of Oncology. 2021 (2021) - p. 1-1 , 2021

Link: https://doi.org/10.1155/..

6

Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in Fi..:

Wang, Bi-Cheng ; Kuang, Bo-Hua ; Xiao, Bo-Ya.
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

7

Efficacy and Safety of First-Line Immunotherapy in Combinat..:

Wang, Bi-Cheng ; Xiao, Bo-Ya ; Li, Peng-Cheng...
Journal of Oncology. 2020 (2020) - p. 1-10 , 2020

Link: https://doi.org/10.1155/..

8

The efficacy and safety of induction chemotherapy combined ..:

Wang, Bi-Cheng ; Xiao, Bo-Ya ; Lin, Guo-He..
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

9

The efficacy and safety of PD-1/PD-L1 inhibitors in breast ..:

Xiao, Bo-Ya ; Lin, Guo-He ; Zhao, Yan-Xia.
Translational Cancer Research. 9 (2020) 6 - p. 3804-3818 , 2020

Link: https://doi.org/10.21037..

10

Irinotecan plus temozolomide in relapsed Ewing sarcoma: an ..:

Wang, Bi-Cheng ; Xiao, Bo-Ya ; Lin, Guo-He
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969362/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in Fi..:

Wang, Bi-Cheng ; Kuang, Bo-Hua ; Xiao, Bo-Ya.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648074/. , 2021

Link: http://www.ncbi.nlm.nih...

12

6 versus 12 months of adjuvant trastuzumab in HER2+ early b..:

Wang, Bi-Cheng ; Xiao, Bo-Ya ; Fan, Ji-Quan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969267/. , 2021

Link: http://www.ncbi.nlm.nih...

13

The efficacy and safety of induction chemotherapy combined ..:

Wang, Bi-Cheng ; Xiao, Bo-Ya ; Lin, Guo-He..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204295/. , 2020

Link: http://www.ncbi.nlm.nih...

14

Prevalence of subthreshold depression and its related facto..:

Ge, Pu ; Tan, Cheng ; Liu, Jia-xin...
Heliyon. 10 (2024) 12 - p. e32595 , 2024

Link: https://doi.org/10.1016/..

15

Susceptibility gene identification and risk evaluation mode..:

Qi, Han ; Xie, Yun-Yi ; Yang, Xiao-Jun...
BMC Genomics. 25 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..